Cardiovascular risk and obesity

C Cercato, FA Fonseca - Diabetology & metabolic syndrome, 2019 - Springer
Background This is an overview of the mechanisms of obesity and its relation to
cardiovascular risks, describing the available treatment options to manage this condition …

Pediatric obesity: Current concepts

DE Greydanus, M Agana, MK Kamboj, S Shebrain… - Disease-a-Month, 2018 - Elsevier
This discussion reflects on concepts of obesity in children and adolescents in the early 21st
century. It includes reflections on its history, definition, epidemiology, diagnostic …

[图书][B] Fundamentals of water treatment unit processes: physical, chemical, and biological

D Hendricks - 2016 - taylorfrancis.com
Carefully designed to balance coverage of theoretical and practical principles,
Fundamentals of Water Treatment Unit Processes delineates the principles that support …

Historical and cultural aspects of obesity: From a symbol of wealth and prosperity to the epidemic of the 21st century

M Sumińska, R Podgórski, K Bogusz‐Górna… - Obesity …, 2022 - Wiley Online Library
Summary World Health Organization defines obesity as abnormal or excess adipose tissue
accumulation. Nowadays, this condition is a serious threat to the public health in most …

The role of medicinal and aromatic plants against obesity and arthritis: A review

AK Paul, R Jahan, A Paul, T Mahboob, TA Bondhon… - Nutrients, 2022 - mdpi.com
Obesity is a significant health concern, as it causes a massive cascade of chronic
inflammations and multiple morbidities. Rheumatoid arthritis and osteoarthritis are chronic …

[HTML][HTML] Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects

PD Montan, A Sourlas, J Olivero, D Silverio… - Annals of …, 2019 - ncbi.nlm.nih.gov
Obesity is a chronic, relapsing, multifactorial disease, which has become a serious threat to
public health globally, as the worldwide prevalence of obesity increases exponentially over …

2014 EASO position statement on the use of anti-obesity drugs

H Toplak, E Woodward, V Yumuk, JM Oppert… - Obesity facts, 2015 - karger.com
The European Association for the Study of Obesity (EASO) considers obesity to be a health,
research, and societal priority [1]. It promotes the study of obesity. Moreover, the EASO …

Naltrexone ER/bupropion ER: a review in obesity management

SL Greig, GM Keating - Drugs, 2015 - Springer
Oral naltrexone extended-release/bupropion extended-release (naltrexone ER/bupropion
ER; Contrave®, Mysimba™) is available as an adjunct to a reduced-calorie diet and …

Naltrexone/bupropion for the treatment of obesity and obesity with Type 2 diabetes

CM Apovian - Future cardiology, 2016 - Taylor & Francis
Contrave® is a combination of naltrexone hydrochloride extended release and bupropion
hydrochloride extended release for the treatment of obesity, and is used with lifestyle …

The analytical challenge in the determination of cathinones, key-players in the worldwide phenomenon of novel psychoactive substances

RAS Couto, LM Gonçalves, F Carvalho… - Critical Reviews in …, 2018 - Taylor & Francis
Since the turn of the century, the synthesis, availability, and use of new psychoactive
substances (NPS) have been increasingly reported worldwide, being considered a complex …